Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: A population-based analysis
Authors:
- William McGahanWMWilliam McGahan
- Mary A. WaterhouseMWMary A. Waterhouse
- Dianne L. O’cOnnellDODianne L. O’cOnnell
- Neil D. MerrettNMNeil D. Merrett
- David GoldsteinDGDavid Goldstein
- David WyldDWDavid Wyld
- Elizabeth A. BurmeisterEBElizabeth A. Burmeister
- Susan J. JordanSJSusan J. Jordan
- Rachel E. NealeRNRachel E. Neale
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 20 (7) , 1458-1464
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (NHMRC) (#613654)
- NHMRC
This publication has 29 references indexed in Scilit:
- CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative TherapyAnnals of Surgical Oncology, 2012
- The prognostic and predictive value of serum CA19.9 in pancreatic cancerAnnals of Oncology, 2012
- Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancerJournal of Clinical Ultrasound, 2008
- Current Utility of Staging Laparoscopy for Pancreatic and Peripancreatic NeoplasmsJournal of the American College of Surgeons, 2008
- The current role of staging laparoscopy for adenocarcinoma of the pancreas: a reviewAnnals of Oncology, 2005
- Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by Computed TomographySurgical Endoscopy, 2005
- Laparoscopy in the staging of pancreatic cancerBritish Journal of Surgery, 2001
- ABH and Lewis histo‐blood group antigens in cancerAPMIS, 2001
- Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundiceEuropean Journal of Surgical Oncology, 2000
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994